Targeted Metabolomics Analysis of Serum Amino Acids in T2DM Patients

被引:2
|
作者
Bao, Li [1 ,2 ]
Wu, Bowen [3 ]
Yang, Chunjing [1 ,2 ]
Xu, Xiqiao [1 ,2 ]
Shi, Zhengyuan [1 ,2 ,4 ]
Jiang, Dechun [1 ,2 ,4 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Pharm, Beijing, Peoples R China
[2] Beijing Key Lab Biocharacterist Profiling Evaluat, Beijing, Peoples R China
[3] Tsinghua Univ, Inst TCM X, Dept Automat, Bioinformat Div,BNRIST,MOE Key Lab Bioinformat, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Shijitan Hosp, Dept Pharm, 10 Tieyi Rd, Beijing 10038, Peoples R China
基金
中国国家自然科学基金;
关键词
diabetes mellitus type 2; T2DM; targeted metabolomics; amino acids; biomarker;
D O I
10.2147/DMSO.S444987
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Amino acids are the important metabolites in the body and play a crucial role in biological processes. The purpose of this study is to provide a profile of amino acids change in the serum of T2DM patients and identify potential biomarkers.Patients and Methods: In this study, we quantitatively determined the serum amino acid profiles of 30 T2DM patients and 30 healthy volunteers. T test and multivariate statistical analysis were used to identify candidate biomarkers with GraphPad Prism 9.5 software and MetaboAnalyst 5.0 on-line platform.Results: Thirty-four amino acids were quantified, and 19 amino acid levels differed significantly between T2DM and Healthy groups. Screened by the specific screening criteria (VIP>1.0; P<0.05; FC>1.5, or FC<0.67) in MetaboAnalyst 5.0 platform, 8 amino acids were identified as potential biomarkers. Pearson rank correlation test showed 14 differential amino acids were significantly correlated with T2DM-related physiological parameters.Conclusion: The results of this study provide theoretical basis for the subsequent development of dietary supplements for the prevention or treatment of T2DM and its complications.
引用
收藏
页码:203 / 212
页数:10
相关论文
共 50 条
  • [41] Surgical or medical therapy for patients with obesity and T2DM?
    Sten Madsbad
    Jens J. Holst
    Nature Reviews Endocrinology, 2016, 12 : 500 - 502
  • [42] Metabolic effects of the Atkins' diet in patients with T2DM
    Sargrad, K
    Homko, C
    Mozzoli, M
    Boden, G
    DIABETES, 2003, 52 : A387 - A387
  • [43] Metabolomics analysis of serum fatty acids in patients with psoriasis
    Esmaeli, Nafiseh
    Rezadoost, Hassan
    Azizpour, Arghavan
    Hoseini, Seyedeh Elham
    Asl, Mahdiyeh Aghabalazadeh
    Aryanian, Zeinab
    Hatami, Parvaneh
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [44] Surgical or medical therapy for patients with obesity and T2DM?
    Madsbad, Sten
    Holst, Jens J.
    NATURE REVIEWS ENDOCRINOLOGY, 2016, 12 (09) : 500 - 502
  • [45] Rationale for exercise in T2DM patients with depression and/or obesity
    Kavookjian, Jan
    DIABETES, 2008, 57 : A305 - A305
  • [47] Predicting renal function decline in patients with T2DM
    George Jerums
    Richard J. MacIsaac
    Nature Reviews Endocrinology, 2014, 10 : 381 - 382
  • [48] Renoprotective effects of dulaglutide in patients with T2DM and CKD
    Charlotte M. Sorensen
    Jens J. Holst
    Nature Reviews Nephrology, 2018, 14 : 659 - 660
  • [49] Achieving target BP and lipids in patients with T2DM
    Hood, RC
    DIABETES, 2002, 51 : A485 - A485
  • [50] Renoprotective effects of dulaglutide in patients with T2DM and CKD
    Sorensen, Charlotte M.
    Holst, Jens J.
    NATURE REVIEWS NEPHROLOGY, 2018, 14 (11) : 659 - 660